ClinicalTrials.govpublic full text
Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma
hepatocellular carcinoma, liver transplantation, adenovirus-thymidine kinase enzyme, gene therapy, immunosuppression, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 901243
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.